Sotera Health Company reported $1.22B of revenue over the trailing twelve months, +8.1% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.22B (to Q2 2026). Net income: $163M, trailing twelve months to Q2 2026. Free cash flow: $113M, trailing twelve months to Q2 2026. EPS: $0.57, trailing twelve months to Q2 2026.

SHCSotera Health Company

Healthcare

$18.06+16% 1Y

$18.06

$13.1352 weeks$19.58

SHC as reported

Sotera Health Company reported $1.22B of revenue over the trailing twelve months, +8.1% on the year before. 11 reported series are charted on this page, each one as filed.

$1.22B

Revenue, trailing twelve months · to Q2 2026 · +8.1% against the twelve months before

Net income: $163M
Net income · +581% year on year · trailing twelve months to Q2 2026
Free cash flow: $113M
Free cash flow · +0.00% year on year · trailing twelve months to Q2 2026
EPS: $0.57
EPS · +533% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for SHC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.22B	+8.1%	Q2 2026
Net income	$163M	+581%	Q2 2026
EPS	$0.57	+533%	Q2 2026
Gross margin	55%	n/a	Q2 2026
Operating margin	27%	n/a	Q4 2024 · 6 quarters behind
Net margin	13%	n/a	Q2 2026
ROE	17%	n/a	Q2 2026
ROA	3.2%	n/a	Q2 2026
ROIC	10%	n/a	Q4 2024 · 6 quarters behind
Free cash flow	$113M	+0.00%	Q2 2026
P/E	31.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.